Perfusion Systems Market Size, Trends and Insights 2025

The global perfusion systems market was valued at USD 1.15 billion in 2023 and is projected to reach USD 1.94 billion by 2034, growing at a CAGR of 4.85% during the forecast period (2024–2034). This growth is fueled by rising organ transplantation needs, technological innovations, and increasing investments in biopharma R&D.

Download the free sample for a quick preview, or get the full report for complete insights and forecasts on the In Vitro Diagnostics Market @ https://www.towardshealthcare.com/download-sample/5234

Key Insights of the Perfusion Systems Market

North America dominated the global market with a 40% share in 2023, led by high transplant volumes and advanced healthcare infrastructure.

Asia-Pacific is expected to grow significantly due to its large aging population and rising organ transplant demand.

Cardiopulmonary perfusion systems held the largest share in 2023, driven by rising cardiovascular surgeries.

Cell perfusion systems are projected to grow rapidly due to increasing application in drug testing, biomanufacturing, and stem cell therapies.

Market Trends Driving Growth

Rising Organ Transplantation

Over 48,000 organ transplants were performed in 2024 (Organ Procurement and Transplantation Network).

North America leads globally in organ donation and transplants, especially the US.

Integration of AI in Perfusion

AI and machine learning improve organ assessment, transplant predictions, and bioprocess automation.

Helps reduce organ discard rates and increases success in organ preservation and matching.

Biopharmaceutical R&D Boost

NIH invested $48 billion annually, and top 20 pharma companies invested $145 billion in 2022-23 in R&D.

Growing focus on continuous biomanufacturing and cell-based therapies fuels perfusion system demand.

Technological Advancements

Launch of next-gen systems like LivaNova’s Essenz Perfusion System and Paragonix’s KidneyVault are transforming the landscape.

Innovations in single-use bioreactors, microfluidic systems, and portable hypothermic perfusion devices increase accessibility and efficiency.

Market Dynamics

Drivers

Increasing chronic illnesses like cardiovascular, respiratory, renal, and liver diseases.

Need for effective organ preservation solutions before transplantation.

Technological shift from cold static storage to machine perfusion.

Restraints

High cost of perfusion systems: ~$456,455 in the US; ₹11,000–18,00,000 in India.

Lack of skilled professionals for complex systems.

Challenges in scalability and adoption, especially in low-income countries.

Opportunities

Expanding use in biopharma for continuous culture and high-yield production.

New applications in stem cell therapy, 3D cell culture, and toxicology testing.

Government initiatives and increasing awareness around organ donation.

Regional Market Insights

North America (Leading Region)

Accounted for 40% of the global market in 2023.

Over 46,000 organ transplants in the US alone.

Backed by advanced healthcare systems, R&D funding, and favorable regulations.

Key players: TransMedics, LivaNova, Medtronic.

Asia-Pacific (Fastest Growing)

High growth due to aging population, chronic disease burden, and government policies promoting organ donation.

India and China rank among top three countries in organ transplants.

Rising healthcare infrastructure and investment in biopharma manufacturing.

Europe

Strong R&D, early technology adoption, and supportive healthcare policies.

Countries like Spain lead globally in donation activity with 48.9 donors per million.

LivaNova, headquartered in the UK, is a major player with regional expansion.

Segment Highlights

Cardiopulmonary Perfusion Systems (Largest Share in 2023)

Used during heart and lung surgeries.

Includes heart-lung machines, oxygenators, cannulas, and monitoring devices.

Increasing cases of open-heart surgery (2M+ annually worldwide).

Cell Perfusion Systems (Fastest Growing Segment)

Supports high-density cell culture for longer durations.

Essential for biomanufacturing, drug screening, stem cell research.

Includes bioreactor, microfluidic, and gravity-driven systems.

VersaLive platform by TIGEM (Italy) is a notable innovation for live cell imaging and transfection.

Ex-vivo Organ Perfusion Systems

Classified into hypothermic and normothermic techniques.

Used to preserve organs like liver, heart, lungs, and kidneys outside the body.

Top Companies in the Perfusion Systems Market

About the Author

sanskruti sathe

Administrator

View All Posts